Terephthalamidine: Past and future Jason S. FishermanEileen M. ClineMichael J. Hawkins Review Articles Pages: 295 - 303
Antitumor activities of new platinum compounds, DWA2114R, NK121 and 254-S, against human leukemia cells sensitive or resistant to cisplatin Hiroyuki KobayashiYuzuru TakemuraTetsuhei Ogawa Preclinical Studies Pages: 313 - 319
Amelioration of thrombocytopenia with concomitant ornithine in sarcomabearing rats receiving high dose difluoromethylornithine V. Bruce Grossie Jr.David M. OtaKenji Nishioka Preclinical Studies Pages: 321 - 326
Analysis of GSH from primary tumors and its role in in vitro chemosensitivities H. ChoyL. SulakJ. J. Feldmeier Preclinical Studies Pages: 327 - 328
Phase II evaluation of bisantrene in refractory multiple myeloma Brian G. M. DurieJohn CrowleyBruce D. Cheson Clinical Studies Pages: 329 - 331
Phase II trial of ICRF-187 in children with solid tumors and acute leukemia Tribhawan VatsBarton KamenJeffrey P. Krischer Clinical Studies Pages: 333 - 337
Phase II trial of indicine N-oxide in relapsed pediatric solid tumors James S. MiserWilliam A. SmithsonDenman Hammond Clinical Studies Pages: 339 - 342
Phase II study of lonidamine in metastatic prostatic carcinoma David J. StewartSusan E. AitkenNorman G. Futter Clinical Studies Pages: 343 - 344
A phase II study of chemotherapy of metastatic colorectal carcinoma with 5-fluorouracil plus cisplatin Robert P. WhiteheadThomas R. FlemingJ. Philip Kuebler Clinical Studies Pages: 345 - 347
Phase II evaluation of menogaril in patients with advanced cervical carcinoma Harry J. Long IIIHarry S. WieandJohn H. Edmonson Clinical Studies Pages: 349 - 351
Phase II study of amonafide in advanced pancreatic adenocarcinoma Kaye LinkeRichard PazdurBernard Levin Clinical Studies Pages: 353 - 356
Hypoprothrombinemia from coadministration of sulofenur (LY 186641) and warfarin: Report of three cases Frank V. FossellaScott M. LippmanRobert L. Wolen Clinical Studies Pages: 357 - 359
Phase II evaluation of amonafide in renal cell carcinoma Celestia S. HiganoPhyllis GoodmanE. David Crawford Clinical Studies Pages: 361 - 363
Phase I–II study of high-dose etoposide in patients with refractory breast cancer Giuseppe FraschiniFrankie A. HolmesGabriel N. Hortobagyi Clinical Studies Pages: 365 - 367
Phase II study of intravenous 6-thioguanine in patients with advanced carcinoma of the pancreas Jaffer A. AjaniRichard PazdurIrwin H. Krakoff Clinical Studies Pages: 369 - 371
Phase II study of fazarabine in advanced head and neck cancer J. Philip KueblerBarbara MetchHarry E. Hynes Clinical Studies Pages: 373 - 374
Phase II trial of intravenous 6-thioguanine for unresectable or metastatic non-small cell bronchogenic carcinoma Frank V. FossellaRodger J. WinnKaren Harper Clinical Studies Pages: 375 - 376
Phase I trial of FK973: Description of a delayed vascular leak syndrome Richard PazdurDah Hsi HoMartin N. Raber Clinical Studies Pages: 377 - 382